2024-12-26 09:01:36 ET
DENVER, Colo., Dec 26, 2024 ( 247marketnews.com )- Coeptis Therapeutics (NASDAQ: COEP ) completed its acquisition of the NexGenAI Affiliates Network platform and launched Coeptis Technologies, a new division that is strategically aimed at diversifying the Company’s growth potential.
Dave Mehalick, President and CEO of Coeptis Therapeutics, commented, “We are excited to integrate the NexGenAI Affiliates Network platform and its AI and RPA-driven tools into our offerings. In industries like biotech, pharma, and MLM, where competition is so high and regulatory challenges are complex, having advanced tools to optimize marketing, streamline operations, and drive measurable results is critical.
“In highly competitive industries such as biotech, pharma, and MLM, having advanced tools to optimize marketing, streamline operations, and drive measurable results is not just beneficial—it’s essential for our success.”
The Lead Advisory behind the development of the NexGenAI Affiliates Network platform, Anshuman Dash, stated, “The integration of NexGenAI’s innovative AI-powered marketing solutions with Coeptis Therapeutics’ forward-thinking approach marks a transformative step forward. This acquisition aligns nicely with Coeptis’ mission to drive innovation in highly regulated industries, revolutionize marketing strategies and operational efficiencies and ultimately deliver greater value to the partners and the industries served.”
The post Coeptis Therapeutics Launches Coeptis Technologies with Completion of NexGenAI Affiliates Network Platform Acquisition appeared first on 24/7 MarketNews .
For further details see:
Coeptis Therapeutics Launches Coeptis Technologies with Completion of NexGenAI Affiliates Network Platform Acquisition
